VEON (VEON) files Form 6-K with press release and data pack
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
VEON Ltd. filed a Form 6-K as a foreign private issuer, primarily to furnish materials released on November 10, 2025. The submission includes a press release, a set of presentation materials, and a supplemental factbook, attached as Exhibits 99.1, 99.2, and 99.3.
Positive
- None.
Negative
- None.
FAQ
What does VEON (VEON) report in its November 2025 Form 6-K?
VEON’s Form 6-K reports that it furnished a press release, presentation materials, and a supplemental factbook dated November 10, 2025. These documents are attached as Exhibits 99.1, 99.2 and 99.3 for investors seeking additional detail.
Which exhibits are included in VEON (VEON) November 2025 Form 6-K?
The Form 6-K includes three key exhibits: a press release as Exhibit 99.1, presentation materials as Exhibit 99.2, and a supplemental factbook as Exhibit 99.3, each dated November 10, 2025 and furnished for investor information.
Why did VEON (VEON) file this Form 6-K as a foreign private issuer?
VEON filed this Form 6-K to furnish investor information as a foreign private issuer under the Exchange Act. The filing formally provides its November 10, 2025 press release, presentation materials, and supplemental factbook to the U.S. market.
What type of annual report does VEON (VEON) file with the SEC?
VEON indicates that it files its annual reports on Form 20-F with the SEC. This confirms it follows the foreign private issuer reporting framework rather than the domestic Form 10-K typically used by U.S.-based public companies.
Who signed VEON (VEON) November 2025 Form 6-K and in what role?
The Form 6-K was signed on behalf of VEON Ltd. by Vitaly Shmakov, who is identified as Acting Group General Counsel. This signature confirms the filing was authorized by a senior legal executive of the company.